They were the Preliminary Results, More detailed Fully Completed...

They were the Preliminary Results,
More detailed Fully Completed and Compiled Results Announcement should not be too far away....

As the Company Stated:
"The study met the primary endpoint and key secondary endpoints.
Further data analysis and interpretation remains ongoing
with the full results to be published on ASX
and in a leading scientific journal."

The Fully Completed and Compiled Phase II/III Autism Spectrum Disorder Clinical Trial Results,
Will obviously contain far more detail.

With Graphs, Charts, Comparisons, Stats, Etc,
To Further explain the Excellent Results in More Detail.
As well as in a way that it easily understood by Shareholders
The General Public and
Potential Partners / Big Pharma Co's Etc.

It's a huge market that can really help a lot of people,
It also has the potential to significantly increase in value....